Fixed-Dose Artesunate–Amodiaquine Combination vs Chloroquine for Treatment of Uncomplicated Blood Stage P. vivax Infection in the Brazilian Amazon: An Open-Label Randomized, Controlled Trial | Zendy

André M. Siqueira | Zendy; Aline Alencar | Zendy; Gisely Cardoso de Melo | Zendy; Belisa L. Magalhães | Zendy; Kim Machado | Zendy; Aristóteles C. Alencar Filho | Zendy; Andrea Kuehn | Zendy; Marly M. Marques | Zendy; Monica Costa Manso | Zendy; Ingrid Felger | Zendy; José Luiz Fernandes Vieira | Zendy; Valérie Lameyre | Zendy; Cláudio Tadeu DanielRibeiro | Zendy; Marcus Lacerda | Zendy

Open Access

Fixed-Dose Artesunate–Amodiaquine Combination vs Chloroquine for Treatment of Uncomplicated Blood Stage P. vivax Infection in the Brazilian Amazon: An Open-Label Randomized, Controlled Trial

Author(s) -

André M. Siqueira,

Aline Alencar,

Gisely Cardoso de Melo,

Belisa L. Magalhães,

Kim Machado,

Aristóteles C. Alencar Filho,

Andrea Kuehn,

Marly M. Marques,

Monica Costa Manso,

Ingrid Felger,

José Luiz Fernandes Vieira,

Valérie Lameyre,

Cláudio Tadeu DanielRibeiro,

Marcus Lacerda

Publication year - 2016

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciw706

Subject(s) - medicine , artesunate , fixed dose combination , randomized controlled trial , amodiaquine , adverse effect , artemisinin , plasmodium vivax , gastroenterology , surgery , malaria , plasmodium falciparum , immunology

Despite increasing evidence of the development of Plasmodium vivax chloroquine (CQ) resistance, there have been no trials comparing its efficacy with that of artemisinin-based combination therapies (ACTs) in Latin America.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research